Alphabet Inc.’s life sciences division Verily is putting on hold one of the company’s oldest and highest-profile projects, a smart contact lens designed to help monitor sugar levels.

For the first time, EPGL reveals the “Omega” contact lens under development with InWith Corp. The patent pending “Omega” is designed to correct vision anytime by changing the curvature of the lenses on-demand, via smart phone or other mobile devices.

Verily is launching a four-year study with about 10,000 participants to understand how people transition from being healthy to becoming sick.

MOUNTAIN VIEW, Calif. – Google Inc. is stepping closer to developing a device to draw blood for medical testing without needles, Wired reported Monday morning. The Internet giant filed a patent application Dec. 3 on a gas-based system designed to draw blood from a fingertip to be used to test blood sugar levels. According to […]

ATLANTA – Alcon (ACL), a division of Novartis (NVS), is investing $250 million into an expansion of its Atlanta-area facility that will add more than 300 jobs, the Atlanta Business Chronicle reported this morning. The expansion will allow Alcon to focus on the manufacturing and development of contact lenses, including Dailies, AquaComfort Plus, Dailies Total1 […]